190 related articles for article (PubMed ID: 37473565)
41. ADMNet: Adaptive-Weighting Dual Mapping for Online Tracking With Respiratory Motion Estimation in Contrast-Enhanced Ultrasound.
Li MD; Hu HT; Ruan SM; Cheng MQ; Chen LD; Huang ZR; Li W; Lin P; Yang H; Kuang M; Lu MD; Huang QH; Wang W
IEEE Trans Image Process; 2024; 33():58-68. PubMed ID: 37988213
[TBL] [Abstract][Full Text] [Related]
42. The real-time ultrasonography for fusion image in glioma neurosugery.
Wu DF; He W; Lin S; Zee CS; Han B
Clin Neurol Neurosurg; 2018 Dec; 175():84-90. PubMed ID: 30384121
[TBL] [Abstract][Full Text] [Related]
43. Incorporation of contrast-enhanced ultrasound in the differential diagnosis for breast lesions with inconsistent results on mammography and conventional ultrasound.
Shao SH; Li CX; Yao MH; Li G; Li X; Wu R
Clin Hemorheol Microcirc; 2020; 74(4):463-473. PubMed ID: 31868661
[TBL] [Abstract][Full Text] [Related]
44. CEUS Versus MRI in Evaluation of the Effect of Microwave Ablation of Breast Cancer.
Liu S; Cai W; Luo Y; Dou J; Wu J; Wu H; Han Z; Yu J; Liang P
Ultrasound Med Biol; 2022 Apr; 48(4):617-625. PubMed ID: 35063290
[TBL] [Abstract][Full Text] [Related]
45. Breast tumor size assessment: comparison of conventional ultrasound and contrast-enhanced ultrasound.
Jiang YX; Liu H; Liu JB; Zhu QL; Sun Q; Chang XY
Ultrasound Med Biol; 2007 Dec; 33(12):1873-81. PubMed ID: 17686569
[TBL] [Abstract][Full Text] [Related]
46. The clinical value of conventional ultrasound combined with contrast-enhanced ultrasound in the evaluation of BI-RADS 4 lesions detected by magnetic resonance imaging.
Guo W; Li F; Jia C; Wang T; Zhang X; Yao G; Shi X; Bai M
Br J Radiol; 2022 Aug; 95(1136):20220025. PubMed ID: 35604699
[TBL] [Abstract][Full Text] [Related]
47. Value of multimodality imaging in the diagnosis of breast lesions with calcification: A retrospective study.
Tong W; Zhang X; Luo J; Pan F; Liang J; Huang H; Li M; Cheng M; Pan J; Zheng Y; Xie X
Clin Hemorheol Microcirc; 2020; 76(1):85-98. PubMed ID: 32538829
[TBL] [Abstract][Full Text] [Related]
48. Pitfalls of Contrast Enhanced Ultrasound (CEUS) in determination of breast tumor biological dignity.
Lehotska V; Rauova K; Vanovcanova L
Neoplasma; 2018; 65(1):124-131. PubMed ID: 29322796
[TBL] [Abstract][Full Text] [Related]
49. Contrast-enhanced ultrasonography and blue dye methods in detection of sentinel lymph nodes following neoadjuvant chemotherapy in initially node positive breast cancer.
Wu X; Tang L; Huang W; Huang S; Peng W; Hu D
Arch Gynecol Obstet; 2020 Sep; 302(3):685-692. PubMed ID: 32602000
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of sonazoid (perflubutane) for contrast-enhanced ultrasound in the differentiation of focal breast lesions: phase 3 multicenter clinical trial.
Miyamoto Y; Ito T; Takada E; Omoto K; Hirai T; Moriyasu F
AJR Am J Roentgenol; 2014 Apr; 202(4):W400-7. PubMed ID: 24660739
[TBL] [Abstract][Full Text] [Related]
51. Adjunctive targeted contrast-enhanced ultrasonography for the work-up of Breast Imaging Reporting and Data System category 3 and 4 lesions.
Zhang XL; Guan J; Li MZ; Liu MJ; Guo Y; Zheng YL; Yang Z; Yang JY
J Med Imaging Radiat Oncol; 2016 Aug; 60(4):485-91. PubMed ID: 27162117
[TBL] [Abstract][Full Text] [Related]
52. The clinical role of contrast enhanced ultrasound in differential diagnosis of BI-RADS 4 breast disease.
Quan J; Hong Y; Zhang X; Mei M; You X; Huang P
Clin Hemorheol Microcirc; 2019; 72(3):293-303. PubMed ID: 30856103
[TBL] [Abstract][Full Text] [Related]
53. Value of contrast-enhanced ultrasound in the diagnosis of breast US-BI-RADS 3 and 4 lesions with calcifications.
Cheng M; Tong W; Luo J; Li M; Liang J; Pan F; Pan J; Zheng Y; Xie X
Clin Radiol; 2020 Dec; 75(12):934-941. PubMed ID: 32814625
[TBL] [Abstract][Full Text] [Related]
54. Homogeneously enhancing breast lesions on contrast enhanced US: differential diagnosis by conventional and contrast enhanced US findings.
Fujimitsu R; Shimakura M; Urakawa H; Morita A; Shinagawa Y; Sakamoto K; Yoshimitsu K
Jpn J Radiol; 2016 Jul; 34(7):508-14. PubMed ID: 27142527
[TBL] [Abstract][Full Text] [Related]
55. Contrast-enhanced lymphatic US can improve the preoperative diagnostic performance for sentinel lymph nodes in early breast cancer.
Niu Z; Gao Y; Xiao M; Mao F; Zhou Y; Zhu Q; Jiang Y
Eur Radiol; 2023 Mar; 33(3):1593-1602. PubMed ID: 36152038
[TBL] [Abstract][Full Text] [Related]
56. Modified contrast-enhanced ultrasonography with the new high-resolution examination technique of high frame rate contrast-enhanced ultrasound (HiFR-CEUS) for characterization of liver lesions: First results.
Jung EM; Moran VO; Engel M; Krüger-Genge A; Stroszczynski C; Jung F
Clin Hemorheol Microcirc; 2023; 83(1):31-46. PubMed ID: 35466932
[TBL] [Abstract][Full Text] [Related]
57. Feasibility of dynamic three-dimensional contrast-enhanced ultrasound in focal liver lesions: Image quality evaluation and correlation of quantification with two-dimensional contrast-enhanced ultrasound.
Cao J; Dong Y; Fan P; Mao F; Wang W
Clin Hemorheol Microcirc; 2019; 72(3):305-316. PubMed ID: 30856104
[TBL] [Abstract][Full Text] [Related]
58. Quantitative contrast-enhanced ultrasound evaluation of pathological complete response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy.
Wan CF; Liu XS; Wang L; Zhang J; Lu JS; Li FH
Eur J Radiol; 2018 Jun; 103():118-123. PubMed ID: 29803376
[TBL] [Abstract][Full Text] [Related]
59. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
[TBL] [Abstract][Full Text] [Related]
60. The value of preoperative sentinel lymph node contrast-enhanced ultrasound for breast cancer: a large, multicenter trial.
Li J; Li H; Guan L; Lu Y; Zhan W; Dong Y; Gu P; Liu J; Cheng W; Na Z; Tang L; Du Z; Yang L; Hai S; Yang C; Zheng Q; Zhang Y; Wang S; Li F; Fu J; Lu M
BMC Cancer; 2022 Apr; 22(1):455. PubMed ID: 35473499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
